BR100 Decreased By (-1.07%)
BR30 Decreased By (-1.47%)
KSE100 Decreased By (-0.89%)
KSE30 Decreased By (-1.04%)
BECO 5.57 Decreased By ▼ -0.26 (-4.46%)
BML 60.50 Increased By ▲ 2.60 (4.49%)
BOP 33.26 Decreased By ▼ -0.53 (-1.57%)
CNERGY 8.04 Decreased By ▼ -0.11 (-1.35%)
DCL 11.31 Decreased By ▼ -0.48 (-4.07%)
FCCL 53.01 Decreased By ▼ -0.48 (-0.9%)
FCSC 5.37 Decreased By ▼ -0.03 (-0.56%)
FFL 17.62 Decreased By ▼ -0.22 (-1.23%)
FNEL 1.32 Increased By ▲ 0.02 (1.54%)
HUMNL 11.15 Increased By ▲ 0.04 (0.36%)
KEL 7.87 Decreased By ▼ -0.15 (-1.87%)
KOSM 5.34 Decreased By ▼ -0.11 (-2.02%)
MLCF 85.15 Decreased By ▼ -2.25 (-2.57%)
NBP 181.75 Decreased By ▼ -2.49 (-1.35%)
PACE 11.55 Decreased By ▼ -0.07 (-0.6%)
PAEL 39.50 Decreased By ▼ -0.75 (-1.86%)
PIAHCLA 25.61 Decreased By ▼ -0.51 (-1.95%)
PIBTL 17.15 Increased By ▲ 0.01 (0.06%)
PPL 224.75 Decreased By ▼ -3.98 (-1.74%)
PRL 34.30 Decreased By ▼ -0.19 (-0.55%)
PTC 65.00 Decreased By ▼ -2.54 (-3.76%)
SEARL 89.81 Decreased By ▼ -1.12 (-1.23%)
SSGC 26.37 Decreased By ▼ -0.46 (-1.71%)
TELE 8.43 Decreased By ▼ -0.10 (-1.17%)
THCCL 69.18 Increased By ▲ 3.04 (4.6%)
TPLP 10.33 Increased By ▲ 1.00 (10.72%)
TREET 24.22 Decreased By ▼ -0.29 (-1.18%)
TRG 69.55 Decreased By ▼ -2.06 (-2.88%)
WAVES 11.03 Increased By ▲ 0.05 (0.46%)
WTL 1.27 Decreased By ▼ -0.01 (-0.78%)
Business & Finance

Inquiry against DRAP officer ordered

Published February 7, 2018 Updated February 7, 2018 02:36pm

ISLAMABAD: Chairman National Accountability Bureau (NAB), Justice (Retd) Javed Iqbal Wednesday ordered inquiry against officer of Drug Regulatory Authority of Pakistan (DRAP), Sheikh Akhtar Hussein for having assets beyond known sources of income and declaring him deceased in two references of NAB.

The Chairman also took notice of appointing Akhtar as Chief Executive Officer of DRAP in BS-19 against post of BS-21 despite accusations of corruption and NAB inquiry. Besides, no departmental inquiry was conducted against him with regard to his assets beyond known sources of income.

NAB Rawalpindi has been directed to present inquiry report against Akhtar Hussain, NAB announced here.

It merits mentioning here that NAB is also conducting inquiry against Aslam Afghani, former Chief Executive DRAP, Ministry of National Health Services, who had been appointed CEO despite owing a private pharmaceutical company in contrary to law. Afghani played decisive role in enhancing medicine prices.

His company got benefit while millions of people had borne burden of medicines on higher rates.

 

Copyright APP (Associated Press of Pakistan), 2018
 

 

 

 

Comments

Comments are closed for this article.